在绝经后的骨质疏松症中,在服用丹诺苏马布后进行罗莫苏马布和丹诺苏马布组合治疗
Giovanni Adami1, Francesco Pollastri1, Angelo Fassio1
1Rheumatology Unit, University of Verona, Verona, Italy.
Arthritis & rheumatology (Hoboken, N.J.)
|December 2, 2025
概括
在更年期后的骨质疏松症患者中,将罗莫苏祖马布添加到德诺苏祖马布治疗中并没有减弱罗莫苏祖马布的合成反应. 这种组合可能为那些在denosumab.com时经历骨折的人提供一个有价值的治疗选择.
科学领域:
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学 骨生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 长期使用德诺苏马布治疗可能会在停止治疗后出现反弹骨损失的风险.
- 对于在denosumab治疗期间骨折的患者,正在探索将romosozumab添加到denosumab中.
研究的目的:
- 为了研究在绝经后骨质疏松症中将罗莫苏祖马布与德诺苏马布结合使用的效果.
- 为了评估denozumab是否会抑制对romosozumab的合成反应.
主要方法:
- 一个36个月的回顾性和前性研究,与得分匹配.
- 两个组:德诺苏玛布+罗莫苏玛布与单独的德诺苏玛布.
- 评估了骨矿物质密度和骨循环标记 (CTX,P1nP).
主要成果:
- 组合疗法显示,对骨矿物质密度更大改善的趋势不显著.
- 当添加到denosumab时,Romosozumab显著增加了P1nP (骨形成标记物).
结论:
- 持续的denosumab治疗不会抑制romosozumab的合成效应.
- 将罗莫苏祖马布与登苏祖马布结合使用可能是骨质疏松症患者在服用登苏祖马布时骨折的有益策略.
相关概念视频
Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
576
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
576
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
790
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
790


